Thuan Nghiem Duc

Prof. Dr. Thuan Nghiem Duc

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Clinical Medicine Insights: Oncology
Verified
Journal Article
Open access
TMTri Bui Dang Minh
Tri Bui Dang Minh
TDThuan Nghiem Duc
Thuan Nghiem Duc
VTVan Phan Nguyen Thanh
Van Phan Nguyen Thanh
TLTuan Dinh Le
Tuan Dinh Le
MTMinh Duc Tong
Minh Duc Tong
TDThanh Bui Duc
Thanh Bui Duc
Background: The B-type rafkinase (BRAF) V600E gene mutation plays an important role in the pathogenesis, diagnosis, and prognosis of thyroid carcinoma. This study was conducted to investigate the rate of the BRAF V600E mutation, the relationships between the BRAF V600E gene mutation and some immunohistochemical markers, and recurrence rate in patients with differentiated thyroid cancer. Method: The study was conducted by a descriptive and longitudinal follow-up method on 102 thyroid carcinoma patients at 103 Military Hospital, Hanoi, Vietnam. All patients were identified with the BRAF V600E gene mutation by real-time polymerase chain reaction. Results: The rate of BRAF V600E gene mutation in patients with thyroid cancer was 60.8%. Patients with BRAF V600E gene mutation had a significantly higher rate of positive cyclooxygenase 2 (COX-2) and Ki67 markers than those without the mutation (COX-2: odds ratio [OR] = 2.93; 95% confidence interval [CI] = 1.27-6.74, P = .011; Ki67: OR = 3.41; 95% CI = 1.31-8.88, P = .01). A statistically significant relationship was identified between the rate of BRAF V600E mutation and the rate of positive Hector Battifora mesothelial 1 (HBME-1) (B = −1.040; P = .037) and COX-2 (B = −1.123; P = .023) markers. The recurrence rate in patients with BRAF V600E gene mutation was significantly higher than that in those without the mutation ( P = .007). The mean of the recurrence time of patients with BRAF V600E mutation was significantly lower than that in those without the mutation ( P = .011). Conclusions: A high prevalence of BRAF V600E gene mutation was found in thyroid carcinoma patients. The rates of positive HBME-1, COX-2, and Ki67 markers were significantly correlated to BRAF V600E gene mutation. Patients with BRAF V600E gene mutation showed a significantly higher relapse rate and earlier relapse time than those without the mutation.

1 January 2025 in Medical Devices: Evidence and Research
Verified
Journal Article
Open access
PDF file
HVHai Anh Vu
Hai Anh Vu
NNNam Van Nguyen
Nam Van Nguyen
TLTuan Dinh Le
Tuan Dinh Le
SNSon Tien Nguyen
Son Tien Nguyen
ALAnh Viet Le
Anh Viet Le
TDThuan Nghiem Duc
Thuan Nghiem Duc
Background: Empyema patients with poor physical condition and severe comorbidities face a significant challenge, with difficulties in choosing appropriate treatment methods, limited treatment outcomes, and a high rate of complications and mortality. Objective: To comment on the indications and to evaluate the treatment outcomes of pleural empyema in patients with poor physical condition and severe comorbidities by thoracoscopic surgery. Methods: An observational study on 12 patients treated at the Department of Thoracic Surgery – Military Hospital 103, from January 2017 to December 2022. Results: The mean of age was 63.4 ± 12.4 years old, with a male/female ratio of 5/1. In this study, 83.3% of cases were presented with stage II empyema. The mean Karnofsky score was 50.0 ± 6.1. Some comorbidities contained chronic obstructive pulmonary disease (COPD) (25.0%), spontaneous esophageal perforation (16.7%), liver cancer, cirrhosis, esophageal cancer, end-stage renal failure – chronic dialysis (8.7%). The surgery procedures were efficient with a short duration (65.6 ± 9.4 minutes), low incidence of blood transfusion (8.3%), and lower rate of postoperative complications (surgical wound infection 8.3%). The length of postoperative stay was 16.8 ± 9.9 days. Pleural drainage was removed in 11 out of 12 cases after an average of 60.1 ± 8.5 days, while one patient had their drainage retained due to esophageal cancer. The total recovery rate at the 1-year follow-up was 91.7%. Conclusion: Video-Assisted Thoracoscopic Surgery (VATS) exhibits positive outcomes in treating stage I and II pleural empyema patients who incurred severe comorbidities.

25 March 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
HAHai Vu Anh
Hai Vu Anh
NNNam Van Nguyen
Nam Van Nguyen
TLTuan Dinh Le
Tuan Dinh Le
SNSon Tien Nguyen
Son Tien Nguyen
BNBinh Van Nguyen
Binh Van Nguyen
HDHoang Huy Duong
Hoang Huy Duong
Background: Video-assisted thoracoscopic Surgery (VATS) bullectomy and pleurodesis for the treatment of spontaneous pneumothorax continue to garner significant attention and discussion regarding their effectiveness in preventing recurrent pneumothorax. Objectives: This study aimed to evaluate the surgical results and prevent recurrence after 10 years using bullectomy and mechanical pleurodesis with VATS. Study population and methodology: This descriptive longitudinal follow-up study included 118 patients with primary spontaneous pneumothorax who underwent bullectomy and mechanical pleurodesis by VATS at Pham Ngoc Thach Hospital, Ho Chi Minh City and Military Hospital 103, Hanoi, Vietnam, between January 2007 and June 2013, with a postoperative follow-up of 120 months. The study concluded in June 2023. Results: The average age of the patients was 28.2 ± 10.2 years, with a male-to-female ratio of 6.4:1. The rates of postoperative complications and recurrence during the 10-year follow-up period were 7.6% and 2.6%, respectively. Factors such as gender, smoking history, history of pneumothorax, technique for suturing and excising air leaks and bullae, and prolonged air leak after VATS for more than 5 days were not associated with the postoperative recurrence rate (p>0.05). Pleural abrasion and pleurectomy had equivalent pooled recurrence rates after 10 years (3.89% vs. 0, p>0.05). However, pleural abrasion had several advantages over pleurectomy, including shorter surgical time (53.1 ± 16.5 min vs. 78.1 ± 31.0 min, p< 0.01), reduced intraoperative blood loss (78.9 ± 76.4 mL vs. 152.1 ± 362.6 mL, p< 0.01), and reduced postoperative pain (p< 0.01). Conclusion: Application VATS for bullectomy and mechanical pleurodesis for the treatment of primary spontaneous pneumothorax shows promising results, with a low 10-year postoperative recurrence rate (2.6%). Pleural abrasion and pleurectomy had equivalent pooled recurrence rates after 10 years. However, pleural abrasion has several advantages over pleurectomy: shorter surgical time, reduced intraoperative blood loss, and reduced postoperative pain